⌘K
Loading ticker…
Equillium, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Equillium, Inc. Common Stock (EQ) has a 3-month relative strength percentile of 89 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 97. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 11.7%, relative volume 0.37×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 89, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
EQ is in a stage 2 uptrend, week 5. Currently in a 15-day base; basing ADR 9.2% (broad 11.0%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 23.8% / 77.2%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
EQ is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $3M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $3M |
| VXFVanguard Extended Market ETF | 0.00% | $692K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EQ Jan avg: -2.61% median: -3.25% win: 50% σ: 11.05% n: 4 2022-04-12 → 2026-05-29 | EQ Feb avg: 61.09% median: 23.76% win: 75% σ: 102.07% n: 4 2022-04-12 → 2026-05-29 | EQ Mar avg: -16.66% median: -13.94% win: 25% σ: 24.72% n: 4 2022-04-12 → 2026-05-29 | EQ Apr avg: -12.52% median: -14.79% win: 40% σ: 17.37% n: 5 2022-04-12 → 2026-05-29 | EQ May avg: 7.36% median: 0.67% win: 60% σ: 19.78% n: 5 2022-04-12 → 2026-05-29 | EQ Jun avg: -17.35% median: -18.79% win: 25% σ: 30.97% n: 4 2022-04-12 → 2026-05-29 (current) | EQ Jul avg: 9.71% median: 8.06% win: 75% σ: 10.54% n: 4 2022-04-12 → 2026-05-29 | EQ Aug avg: 105.19% median: 33.14% win: 100% σ: 160.48% n: 4 2022-04-12 → 2026-05-29 | EQ Sep avg: -16.77% median: -18.10% win: 0% σ: 5.76% n: 4 2022-04-12 → 2026-05-29 | EQ Oct avg: -11.47% median: -8.81% win: 25% σ: 15.91% n: 4 2022-04-12 → 2026-05-29 | EQ Nov avg: -11.17% median: -11.76% win: 25% σ: 20.78% n: 4 2022-04-12 → 2026-05-29 | EQ Dec avg: 14.98% median: 12.15% win: 50% σ: 45.34% n: 4 2022-04-12 → 2026-05-29 |